Today: 9 April 2026
Subscribe
Browse Category

NASDAQ:CRDO 14 October 2025 - 19 October 2025

AI Boom’s Hidden Gem: Credo (CRDO) Stock Soars on $500 “Purple” Cables and Big Partnerships

AI Boom’s Hidden Gem: Credo (CRDO) Stock Soars on $500 “Purple” Cables and Big Partnerships

Credo’s stock doubled in 2025, reaching around $143 after a 245% jump in 2024, fueled by soaring demand for its AI data center gear. Fiscal 2025 revenue hit $436.8 million, with net profit at $52.2 million. The company unveiled new 1.6Tbps cables and joined Arm’s AI chip ecosystem in October. CRDO’s market cap stands near $25–26 billion, with JPMorgan rating it Overweight despite high volatility.
19 October 2025
···
Credo Technology (CRDO) Stock Rebounds on AI Partnership as Analysts Eye Long-Term Growth

Credo Technology (CRDO) Stock Rebounds on AI Partnership as Analysts Eye Long-Term Growth

Credo Technology Group shares plunged 13% Tuesday to $129.75 after surging to nearly $150 earlier in the week, then rebounded 6% in pre-market trading Wednesday. The company unveiled new “ZeroFlap” optical transceivers and joined Arm’s Total Design ecosystem to co-develop custom AI silicon. Credo also filed for a $750 million stock offering and acquired Hyperlume for about $40–50 million. Revenue jumped 273% last quarter to $223 million.
15 October 2025
···
AI Data Center Goldmine or Bubble? Credo (CRDO) Stock’s Wild Ride Amid New Deals and Big Hype

AI Data Center Goldmine or Bubble? Credo (CRDO) Stock’s Wild Ride Amid New Deals and Big Hype

Credo Technology shares jumped nearly 8% to $149.90 on Monday, then plunged over 13% to about $130 on Tuesday amid volatile trading. The company launched new “ZeroFlap” optical transceivers for AI data centers and joined Arm’s “Total Design” ecosystem. Credo also acquired Hyperlume for up to $50 million and filed to sell $750 million in new shares. Revenue surged 273% last quarter to $223 million.
14 October 2025
····
1 2 3

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Go toTop